NO178108C - Salts of hydrazones, pharmaceutical preparations containing the salts and the use of the salts - Google Patents

Salts of hydrazones, pharmaceutical preparations containing the salts and the use of the salts

Info

Publication number
NO178108C
NO178108C NO924001A NO924001A NO178108C NO 178108 C NO178108 C NO 178108C NO 924001 A NO924001 A NO 924001A NO 924001 A NO924001 A NO 924001A NO 178108 C NO178108 C NO 178108C
Authority
NO
Norway
Prior art keywords
acids
acid
unsubstituted
substituted
salts
Prior art date
Application number
NO924001A
Other languages
Norwegian (no)
Other versions
NO924001D0 (en
NO178108B (en
NO924001L (en
Inventor
Jaroslav Stanek
Jorg Frei
Giorgio Caravatti
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO924001D0 publication Critical patent/NO924001D0/en
Publication of NO924001L publication Critical patent/NO924001L/en
Publication of NO178108B publication Critical patent/NO178108B/en
Publication of NO178108C publication Critical patent/NO178108C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Cereal-Derived Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to acid addition salts of bases of the formula I <IMAGE> in which A, R1, R2, R3, R4, R5, X and Z have the meanings given in the description, with an acid [PA], which denotes a mono- or polybasic acid selected from carbonic acid, alkanoic acids which are unsubstituted or monosubstituted to polysubstituted, apart from formic acid, unsubstituted acetic acid, lysine and arginine; alkenoic acids which are unsubstituted or substituted, apart from unsubstituted fumaric acid, cycloalkylcarboxylic acids, arylcarboxylic acids, aryl-lower alkylcarboxylic acids in which lower alkyl is unsubstituted or substituted, aryl-lower alkenylcarboxylic acids, heterocyclylcarboxylic acids, alkanesulphonic acids which are unsubstituted or substituted, apart from unsubstituted methanesulphonic acid, aromatic sulphonic acids, alkylsulphuric acids, N-substituted sulphamic acids, organic acids without carboxyl, sulpho, sulphate or phospho groups, and further from pyrophosphoric acid and hydrogen iodide; and tautomers thereof. The acid addition salts are employed for the treatment of disorders which respond to inhibition of S-adenosylmethionine decarboxylase.
NO924001A 1991-10-16 1992-10-15 Salts of hydrazones, pharmaceutical preparations containing the salts and the use of the salts NO178108C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH304191 1991-10-16

Publications (4)

Publication Number Publication Date
NO924001D0 NO924001D0 (en) 1992-10-15
NO924001L NO924001L (en) 1993-04-19
NO178108B NO178108B (en) 1995-10-16
NO178108C true NO178108C (en) 1996-01-24

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924001A NO178108C (en) 1991-10-16 1992-10-15 Salts of hydrazones, pharmaceutical preparations containing the salts and the use of the salts

Country Status (24)

Country Link
EP (1) EP0538193B1 (en)
JP (1) JP2788579B2 (en)
KR (1) KR100265307B1 (en)
AT (1) ATE145896T1 (en)
AU (1) AU658931B2 (en)
CA (1) CA2080545C (en)
CY (1) CY2127B1 (en)
CZ (1) CZ279601B6 (en)
DE (1) DE59207617D1 (en)
DK (1) DK0538193T3 (en)
ES (1) ES2095444T3 (en)
FI (1) FI112212B (en)
GR (1) GR3021903T3 (en)
HK (1) HK1005023A1 (en)
HU (1) HU226954B1 (en)
IL (1) IL103448A (en)
MX (1) MX9205934A (en)
NO (1) NO178108C (en)
NZ (1) NZ244725A (en)
RU (1) RU2081108C1 (en)
SA (1) SA93130417B1 (en)
SG (1) SG43185A1 (en)
SK (1) SK279938B6 (en)
ZA (1) ZA927957B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (en) * 1992-08-26 1998-04-01 Ciba Geigy Ag PROCEDURE FOR OBTAINING BICYCLE AMIDINOHYDRAZONES.
US5840911A (en) * 1995-01-26 1998-11-24 Novartis Ag Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors
CA2477714C (en) * 2002-03-04 2011-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New cinnamic acid salts, processes for the preparation thereof and use thereof as medicament
GT200600316A (en) * 2005-07-20 2007-04-02 SALTS OF 4-METHYL-N- (3- (4-METHYL-IMIDAZOL-1-ILO) -5-TRIFLUOROMETILO-PHENYL) -3- (4-PIRIDINA-3-ILO-PIRIMIDINA-2-ILOAMINO) - BENZAMIDA.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
NO924001D0 (en) 1992-10-15
AU658931B2 (en) 1995-05-04
AU2704092A (en) 1993-04-22
IL103448A (en) 1998-01-04
FI112212B (en) 2003-11-14
JPH05239011A (en) 1993-09-17
CA2080545C (en) 2005-11-29
NZ244725A (en) 1995-05-26
SA93130417B1 (en) 2005-11-12
JP2788579B2 (en) 1998-08-20
KR930007896A (en) 1993-05-20
FI924650A0 (en) 1992-10-14
ES2095444T3 (en) 1997-02-16
ATE145896T1 (en) 1996-12-15
SK315292A3 (en) 1995-04-12
ZA927957B (en) 1993-04-26
RU2081108C1 (en) 1997-06-10
KR100265307B1 (en) 2000-09-15
NO178108B (en) 1995-10-16
MX9205934A (en) 1993-04-01
HK1005023A1 (en) 1998-12-18
NO924001L (en) 1993-04-19
CZ315292A3 (en) 1993-05-12
DK0538193T3 (en) 1996-12-23
CZ279601B6 (en) 1995-05-17
FI924650A (en) 1993-04-17
EP0538193A2 (en) 1993-04-21
HUT63149A (en) 1993-07-28
IL103448A0 (en) 1993-03-15
HU226954B1 (en) 2010-03-29
CY2127B1 (en) 2002-06-21
EP0538193A3 (en) 1993-06-16
EP0538193B1 (en) 1996-12-04
DE59207617D1 (en) 1997-01-16
GR3021903T3 (en) 1997-03-31
SG43185A1 (en) 1997-10-17
HU9203234D0 (en) 1992-12-28
CA2080545A1 (en) 1993-04-17
SK279938B6 (en) 1999-06-11

Similar Documents

Publication Publication Date Title
ES445075A1 (en) Phenylmethylphenoxy propionic acid esters
DE3671370D1 (en) PREPARATIONS FOR TREATING MYCOPLASMOS AND BACTERIAL DISEASES IN POULTRY.
ES8501362A1 (en) Phthalazine substituted aminomethyl benzene derivatives, compositions and use.
IE890177L (en) Piperidinyl derivatives
NO178108C (en) Salts of hydrazones, pharmaceutical preparations containing the salts and the use of the salts
DE69209128D1 (en) Use of indazole methoxyalkanoic acid in the manufacture of a medicament for the treatment of autoimmune diseases
ZA889023B (en) 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them
ES2109988T3 (en) CEPHALOSPORINIC DERIVATIVES.
KR900700098A (en) Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction
ES471686A1 (en) Benz-acylbenzimidazole-2-carboxylic acid derivatives
ES539160A0 (en) A PROCEDURE FOR PREPARING PENEM DERIVATIVES

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees